References
- Tsolakis AV, Portela-Gomes GM, Stridsberg M, Grimelius L, Sundin A, Eriksson BK, et al. Malignant gastric ghrelinoma with hyperghrelinemia. J Clin Endocrinol Metab. 2004;89:3739–44.
- Corbetta S, Peracchi M, Cappello V, Lania A, Lauri E, Vago P, et al. Circulating ghrelin levels in patients with pancreatic and gastrointestinal neuroendocrine tumors: identification of one pancreatic ghrelinoma. J Clin Endocrinol Metab. 2003;88:3117–20.
- Walter T, Chardon L, Hervieu V, Cohen R, Chayvialle J-E, Scoazec J-Y, et al. Major hyperghrelinemia in advanced well-differentiated neuroendocrine carcinomas: report of three cases. Eur J Endocrinol. 2009;161:639–45.
- Bosman FT, Carneiro F, Hruban RH, Theise ND. editors. WHO classification of tumors of the digestive system. Lyon: IARC; 2010. p 133–77.
- Baum RP, Kulkarni HR. Theranostics: From molecular imaging, using Ga-68 labeled tracers and PET/CT, to personalized radionuclide therapy – the Bad Berka experience. Theranostics. 2012;2:437–47.
- Wierup N, Björkqvist M, Weström B, Pierzynowski S, Sundler F, Sjölund K. Ghrelin and motilin are cosecreted from a prominent endocrine cell population in the small intestine. J Clin Endocrinol Metab. 2007;92:3573–81.
- Landerholm K, Falkmer SE, Järhult J, Sundler F, Wierup N. Cocaine- and amphetamine-regulated transcript in nueroendocrine tumors. Neuroendocrinology. 2011;94:228–36.
- Grönberg M, Tsolakis AV, Magnusson L, Janson ET, Saras J. Distribution of obestatin and ghrelin in human tissues: immunoreactive cells in the gastrointestinal tract, pancreas, and mammary glands. J Histochem Cytochem. 2008;56:793–801.
- Latta E, Rotondo F, Leiter LA, Horvath E, Kovacs K. Ghrelin- and serotonin-producing gastric carcinoid. J Gastrointest Cancer. 2012;43:319–23.
- Syversen U, Ramstad H, Gamme K, Qvigstad G, Falkmer S, Waldum HL. Clinical significance of elevated serum chromogranin A levels. Scand J Gastroenterol. 2004;39:969–73.
- Creutzfeldt W, Arnold R, Creutzfeldt C, Deuticke U, Frerichs H, Track NS. Biochemical and morphological investigations of 30 human insulinomas. Correlation between the tumour content of insulin and proinsulin-like components and the histological and ultrastructural appearance. Diabetologia. 1973;9:217–31.
- Caplin ME, Paver M, Cwikla JB, Phan AT, Raderer M, Sedláčková E, et al. Lanreotide in metastatic enteropancreatic neuroendocrine tumors. N Engl J Med. 2014;371:224–33.